ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

September 9, 1977

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012

Broder Hopes To Help “Fundable: Centers, Stops Short Of Promising Compliance With All IOM Points

May 5, 1989

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014